Igg, Igm and Iga Antibodies against the Novel Polyprotein in Active Tuberculosis

Resource type
Date created
Author: Yang, Xiqin
Author: Qie, Shuang
Author: Chen, Kun
Author: Zhao, Ping
Author: Zhang, Li
Author: Wang, Guohua
Author: Zhang, Heqiu
BackgroundThe present study was aimed to evaluate whether IgG, IgM and IgA antibodies levels detected against a novel Mycobacterium tuberculosis polyprotein 38 F-64 F (with 38 F being the abbreviation for 38kD-ESAT6-CFP10 and 64 F for Mtb8.4-MPT64-TB16.3-Mtb8) are suitable for diagnosing active tuberculosis, and for monitoring the efficacy of chemotherapy on TB patients.MethodsIn this study, a total of 371 active TB patients without treatment were selected and categorized into S+/C+ group (n = 143), S-/C+ group (n = 106) or S-/C- group (n = 122). A series of serum samples were collected from 82 active TB patients who had undergone anti-TB chemotherapy for 0–6 months at one month interval. Humoral responses (IgG, IgM and IgA) were determined for the novel Mycobacterium tuberculosis polyprotein using indirect ELISA methods in all of serum samples.ResultsFor S+/C+, S-/C+ and S-/C- active tuberculosis patients before anti-TB chemotherapy, the sensitivities of tests based on IgG were 65.7%, 46.2% and 52.5% respectively; the sensitivities based on IgM were 21.7%, 24.5% and 18.9%; and the sensitivities based on IgA were 25.2%, 17.9% and 23.8%. By combination of three isotypes, for all active tuberculosis patients, the test sensitivity increased to 70.4% with the specificity being 91.5%. After anti-TB chemotherapy, there were no significant differences between groups with different courses of anti-TB chemotherapy.ConclusionsThe novel Mycobacterium tuberculosis polyprotein 38 F-64 F represents potential antigen suitable for measuring IgG, IgM and IgA antibodies. However, the serodiagnostic test based on the 38 F-64 F polyprotein appears unsuitable for monitoring the efficacy of chemotherapy.
Published as
Feng et al. BMC Infectious Diseases 2014, 14 :336 http://www.biomedcentral.com/1471-2334/14/336
Publication title
BMC Infectious Diseases
Document title
Igg, Igm and Iga Antibodies against the Novel Polyprotein in Active Tuberculosis
Copyright statement
Copyright is held by the author(s).
Scholarly level
Peer reviewed?
Member of collection
Attachment Size
1471-2334-14-336.pdf 706.31 KB